Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul D. Semchuk is active.

Publication


Featured researches published by Paul D. Semchuk.


Molecular & Cellular Proteomics | 2005

Localization, Annotation, and Comparison of the Escherichia coli K-12 Proteome under Two States of Growth

Ana Lopez-Campistrous; Paul D. Semchuk; Lorne Burke; Taunja Palmer-Stone; Stephen J. Brokx; Gordon Broderick; Drell Bottorff; Sandra Bolch; Joel H. Weiner; Michael J. Ellison

Here we describe a proteomic analysis of Escherichia coli in which 3,199 protein forms were detected, and of those 2,160 were annotated and assigned to the cytosol, periplasm, inner membrane, and outer membrane by biochemical fractionation followed by two-dimensional gel electrophoresis and tandem mass spectrometry. Represented within this inventory were unique and modified forms corresponding to 575 different ORFs that included 151 proteins whose existence had been predicted from hypothetical ORFs, 76 proteins of completely unknown function, and 222 proteins currently without location assignments in the Swiss-Prot Database. Of the 575 unique proteins identified, 42% were found to exist in multiple forms. Using DIGE, we also examined the relative changes in protein expression when cells were grown in the presence and absence of amino acids. A total of 23 different proteins were identified whose abundance changed significantly between the two conditions. Most of these changes were found to be associated with proteins involved in carbon and amino acid metabolism, transport, and chemotaxis. Detailed information related to all 2,160 protein forms (protein and gene names, accession numbers, subcellular locations, relative abundances, sequence coverage, molecular masses, and isoelectric points) can be obtained upon request in either tabular form or as interactive gel images.


Hypertension | 2008

Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension.

Ana Lopez-Campistrous; Li Hao; Wang Xiang; Dong Ton; Paul D. Semchuk; Joerg Sander; Michael J. Ellison; Carlos Fernandez-Patron

The central nervous system plays a critical role in the normal control of arterial blood pressure and in its elevation in virtually all forms of hypertension. Mitochondrial dysfunction has been increasingly associated with the development of hypertension. Therefore, we examined whether mitochondrial dysfunction occurs in the brain in hypertension and characterized it at the molecular scale. Mitochondria from whole brain and brain stem from 12-week–old spontaneously hypertensive rats with elevated blood pressure (190±5 mm Hg) were compared against those from age-matched normotensive (134±7 mm Hg) Wistar Kyoto rats (n=4 in each group). Global differential analysis using 2D electrophoresis followed by tandem mass spectrometry–based protein identification suggested a downregulation of enzymes involved in cellular energetics in hypertension. Targeted differential analysis of mitochondrial respiratory complexes using the classical blue-native SDS-PAGE/Western method and a complementary combination of sucrose-gradient ultracentrifugation/tandem mass spectrometry revealed previously unknown assembly defects in complexes I, III, IV, and V in hypertension. Interestingly, targeted examination of the brain stem, a regulator of cardiovascular homeostasis and systemic blood pressure, further showed the occurrence of mitochondrial complex I dysfunction, elevated reactive oxygen species production, decreased ATP synthesis, and impaired respiration in hypertension. Our findings suggest that in already-hypertensive spontaneously hypertensive rats, the brain respiratory complexes exhibit previously unknown assembly defects. These defects impair the function of the mitochondrial respiratory chain. This mitochondrial dysfunction localizes to the brain stem and is, therefore, likely to contribute to the development, as well as to pathophysiological complications, of hypertension.


Biochemical Journal | 2006

Saccharomyces cerevisiae Ime2 phosphorylates Sic1 at multiple PXS/T sites but is insufficient to trigger Sic1 degradation

Chantelle Sedgwick; Matthew Rawluk; James M. DeCesare; Sheetal Raithatha; James A. Wohlschlegel; Paul D. Semchuk; Michael J. Ellison; John R. Yates; David T. Stuart

The initiation of DNA replication in Saccharomyces cerevisiae depends upon the destruction of the Clb-Cdc28 inhibitor Sic1. In proliferating cells Cln-Cdc28 complexes phosphorylate Sic1, which stimulates binding of Sic1 to SCF(Cdc4) and triggers its proteosome mediated destruction. During sporulation cyclins are not expressed, yet Sic1 is still destroyed at the G1-/S-phase boundary. The Cdk (cyclin dependent kinase) sites are also required for Sic1 destruction during sporulation. Sic1 that is devoid of Cdk phosphorylation sites displays increased stability and decreased phosphorylation in vivo. In addition, we found that Sic1 was modified by ubiquitin in sporulating cells and that SCF(Cdc4) was required for this modification. The meiosis-specific kinase Ime2 has been proposed to promote Sic1 destruction by phosphorylating Sic1 in sporulating cells. We found that Ime2 phosphorylates Sic1 at multiple sites in vitro. However, only a subset of these sites corresponds to Cdk sites. The identification of multiple sites phosphorylated by Ime2 has allowed us to propose a motif for phosphorylation by Ime2 (PXS/T) where serine or threonine acts as a phospho-acceptor. Although Ime2 phosphorylates Sic1 at multiple sites in vitro, the modified Sic1 fails to bind to SCF(Cdc4). In addition, the expression of Ime2 in G1 arrested haploid cells does not promote the destruction of Sic1. These data support a model where Ime2 is necessary but not sufficient to promote Sic1 destruction during sporulation.


Journal of Chromatography A | 1998

Liquid chromatographic–high-resolution mass spectrometric and tandem mass spectrometric identification of synthetic peptides using electrospray ionization

Paul A. D'Agostino; James R. Hancock; Lionel R. Provost; Paul D. Semchuk; Robert S. Hodges

Liquid chromatography-high-resolution electrospray mass spectrometry (LC-ESI-MS) was investigated for the identification of known and unknown synthetic peptides in a research effort designed to evaluate the applicability of this and complementary MS techniques for peptide characterization and identification. The monoisotopic molecular masses of five related peptides with molecular masses between 2000 and 2500 u were acquired with a resolution of 3000 (10% valley). Under narrow and wide mass range magnetic sector scanning conditions monoisotopic molecular mass errors were typically in the 10-20 and 30-40 ppm range, respectively. Tryptic maps were generated for each peptide following LC-ESI-MS analysis and collisionally activated dissociation (CAD) in the ESI interface resulted in the production of characteristic product ions that enabled amino acid sequencing of the tryptic fragments. Unknown identification was demonstrated during analysis of an incomplete synthetic peptide reaction mixture. The synthesis of an 18 amino acid peptide, LTTAVKKVLTTGLPALIS, was not successful. In its place were six unknown peptides that were identified on the basis of monoisotopic molecular mass and amino acid sequence data. The monoisotopic molecular masses of these unknowns were determined to within 10-20 ppm with a resolution of 3500 (10% valley). Amino acid sequences for the six peptides were generated during ESI-MS-MS analysis. Finally two synthetic peptides differing only by the incorporation of a 13C at leucine were analysed with a resolution of 6000 (10% valley) to confirm that the isotopic distributions were consistent with theoretical expectations.


Letters in Peptide Science | 1996

A method for the facile solid-phase synthesis of gramicidin S and its analogs

David S. Wishart; Leslie H. Kondejewski; Paul D. Semchuk; Brian D. Sykes; Robert S. Hodges

A simple method is described for the facile synthesis of gramicidin S and six other analogs, using standard solidphase synthetic technology and a single solution-phase cyclization step. The peptides were purified to homogeneity and characterized by plasma desorption time-of-flight mass spectrometry and NMR spectroscopy. Complete 1H NMR assignments for all seven peptides (in aqueous solution) are presented. Unlike previous approaches, the presented method is simple, automatable, rapid (less than three days), high-yielding, requires no side-chain protection during cyclization, and appears to be generally applicable to the preparation of a variety of related head-to-tail cyclic peptides.


Techniques in Protein Chemistry | 1995

Design, synthesis and characterization of a water-soluble β-sheet peptide

David S. Wishart; Les H. Kondejewski; Paul D. Semchuk; Cyril M. Kay; Robert S. Hodges; Brian D. Sykes

Publisher Summary Considerable progress has been made in the understanding of helix formation and stabilization; however, the same cannot be said of the situation regarding two other important classes of secondary structure: β-sheets and β-turns. This chapter describes methods that are developed to easily prepare a number of gramicidin S (β-sheet) analogs, using solid phase peptide synthesis and a simple but effective cyclization protocol. The chapter also presents data describing the effects of selected residue substitutions on the solubility and structural stability of these peptides, and also demonstrates on how lengthened (12 residue) analogs of gramicidin S exhibit features of cold denaturation and trifluoroethanol (TFE)-induced structure formation. The chapter discusses success in designing a 12 residue cyclic peptide (peptide 6), which satisfies most of the criteria required of a model β-sheet: it is small, monomeric, water-soluble, pure, mostly amphipathic, reversibly denaturable, composed of only natural amino acids, relatively easily, synthesized, and easily characterized by either CD or NMR. It is expected that these model systems will provide researchers with the detailed information they need to understand the intricacies of β-sheet and β-turn formation in natural proteins.


American Journal of Transplantation | 2005

Localization, Annotation & Comparison of the Escherichia coli K-12 Proteome under Two States of Growth

Ana Lopez-Campistrous; Paul D. Semchuk; L. Burke; T. Palmer-Stone; Stephen J. Brokx; Gordon Broderick; Drell Bottorff; Joel H. Weiner; Michael J. Ellison

Here we describe a proteomic analysis of Escherichia coli in which 3,199 protein forms were detected, and of those 2,160 were annotated and assigned to the cytosol, periplasm, inner membrane, and outer membrane by biochemical fractionation followed by two-dimensional gel electrophoresis and tandem mass spectrometry. Represented within this inventory were unique and modified forms corresponding to 575 different ORFs that included 151 proteins whose existence had been predicted from hypothetical ORFs, 76 proteins of completely unknown function, and 222 proteins currently without location assignments in the Swiss-Prot Database. Of the 575 unique proteins identified, 42% were found to exist in multiple forms. Using DIGE, we also examined the relative changes in protein expression when cells were grown in the presence and absence of amino acids. A total of 23 different proteins were identified whose abundance changed significantly between the two conditions. Most of these changes were found to be associated with proteins involved in carbon and amino acid metabolism, transport, and chemotaxis. Detailed information related to all 2,160 protein forms (protein and gene names, accession numbers, subcellular locations, relative abundances, sequence coverage, molecular masses, and isoelectric points) can be obtained upon request in either tabular form or as interactive gel images.


Archive | 2002

Minimization of side reactions during removal of the formyl protecting group from the ε-amino group of lysine

Paul D. Semchuk; Marc Genest; Leslie H. Kondejewski; Robert S. Hodges

Side-chain protection of lysine residues with the formyl group provides another level of protection during peptide synthesis. This protecting group is stable to both Boc and Fmoc synthesis and cleavage protocols. The small size and low hydrophobicity of this group facilitates post-synthetic manipulations such as peptide conjugation or cyclization reactions of protected peptides. However, removal of the group from the peptide can result in undesirable side reactions, depending on the amino acid composition and deformylation method employed.


Peptide research | 1990

Synthetic model proteins: contribution of hydrophobic residues and disulfide bonds to protein stability.

Robert S. Hodges; Nian E. Zhou; Cyril M. Kay; Paul D. Semchuk


Peptide research | 1988

Protein design using model synthetic peptides.

Robert S. Hodges; Paul D. Semchuk; Ashok K. Taneja; Cyril M. Kay; J.M.R. Parker; Colin T. Mant

Collaboration


Dive into the Paul D. Semchuk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brian D. Sykes

Canadian Institutes of Health Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James R. Hancock

Defence Research and Development Canada

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge